EUCTR2010-022410-11-NL进行中（未招募）不适用
Topical Diclofenac and Vitamin D3 to treat Basal Cell Carcinoma - VitaDi
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- MUMC
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Minimum age 18 years
- •Primary basal cell carcinoma, histologically confirmed
- •Nodular of micronodular histological subtype
- •Comorbidities may not interfere with study treatment
- •Capable to understand instructions
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age under 18 years
- •Tumors located at the H-zone of the face
- •Deficient histological conformation
- •Proven or suspected malignancy of other organs
- •Not capable of comprehending instructions
- •Incompetent
- •Use of oral NSAIDs during the trial period or within 30 days before starting therapy
- •Use of oral vitamin D (containing) supplements during the trial period or within 30 days before starting therapy
研究者
相似试验
已完成
3 期
Topical Vitamin D3, Diclofenac or a combination of both to treat Basal Cell Carcinoma10040900non-melanoma skin cancerbasal cell carcinomaNL-OMON36360Medisch Universitair Ziekenhuis Maastricht128
已完成
2 期
Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell CarcinomaBasal Cell CarcinomaNCT01358045Maastricht University Medical Center128
已完成
3 期
Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee OsteoarthritisOsteoarthritis, KneeNCT00108992Nuvo Research Inc.750
尚未招募
2 期
Investigating the impact of topical vitamin D on anogenital wartsIRCT20230124057201N4Tehran University of Medical Sciences30
尚未招募
3 期
Effectiveness of Diclofenac in the form of transdermal patch and oral tablet after tooth extractioCTRI/2021/01/030229Dr Ahana Mol U K